Factual end-of-day data for SUNPHARMA: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 6,48,845 shares was well below the 20-day average (0.3×).
SUNPHARMA's delivery share of 67.9% was above its 20-day average of 64.5%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 776 shares on the buy side vs 64,992 on the sell side.
Largest single sell-side trade: 2,031 shares at ₹1,899.50.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 43.3 |
| 50-day EMA | ₹1,907.58 — close is below |
| 200-day EMA | ₹1,811.07 — close is above |
| SuperTrend (10, 3) | ₹1,975.51 — close is below the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
SUNPHARMA is a large-cap NSE stock in the Pharma sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹4,30,321 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 67.9% of SUNPHARMA's traded volume was marked for delivery (4,40,446 shares delivered). The 20-day average delivery is 64.5%.
SUNPHARMA closed at ₹1,899.50 on 26 Aug 2026 (-1.17% vs the previous close).
52-week high ₹2,046.90, 52-week low ₹1,548.00. The latest close is -7.20% from the 52-week high.